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Abstract
Background: Despite efforts to prevent postoperative discomfort, there are still many immediate side effects 
associated with the surgical extraction of impacted lower third molars. Cicatrization is a physiological process 
through which the loss of integrity of oral mucosa is recovered and damaged tissues are repaired. Bexident Post 
(ISDIN, Spain) is a topical gel that contains chitosan, 0.2% chlorhexidine, allantoin and dexpanthenol. While this 
gel has many clinical indications, there are no published clinical trials evaluating its use in impacted mandibular 
third molar surgery. 
This study aims to clinically evaluate the efficacy of a gel containing chitosan, 0.2% chlorhexidine, allantoin and 
dexpanthenol on wound healing and reduction of postoperative side effects and complications after extraction of 
an impacted mandibular third molar. 
Material and Methods: A split-mouth design study was carried out on a total of 50 bilaterally and symmetrically 
impacted third molar extractions, which were randomly placed into either a control group (CG=25) or an experi-
mental group (EG=25). Patients were all informed of the purpose of the study and provided written consent. All 
procedures were carried out by the same dental practitioner, in accordance with standard surgical protocol. A dif-
ferent dental practitioner, unaware of which treatment had been applied, provided follow-up care. The EG applied 
10 ml of topical gel composed of chitosan, 0.2% chlorhexidine, allantoin and dexpanthenol to the surgical wound 
three times a day for 10 days, patients in the CG did not apply any gel.
Results: The groups were homogeneous insofar as potentially confounding variables. No significant findings were 
found regarding postoperative swelling and pain. Neither of the groups displayed poor healing or infectious com-
plications of the wound during the postoperative period. In all the recorded follow-ups (Day 7 p=0.001, and Day 
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14 p=0.01), the wound’s aesthetic appearance was better in the EG. Overall treatment tolerance was satisfactory and 
similar in both groups.
Conclusions: The gel composed of chitosan, 0.2% chlorhexidine, allantoin and dexpanthenol did not aid in patients’ 
postoperative comfort; however, improved wound healing was observed.
Key Words: Impacted lower third molar, postoperative wound healing, chitosan, chlorhexidine, allantoin, dexpan-
thenol, postoperative period.
Introduction
Evolutionary reasons explain the lack of space jawbones 
have for proper eruption of a mandibular third molar, 
making it the most common dental impaction. Impacted 
third molars may lead to formation of cysts and tumors, 
resorption of adjacent teeth or pain of unknown origin. 
Preventive third molar extraction is recommended when 
risk of surgery is not higher than the benefit (1).
Recent studies reveal postoperative complications to 
be one of the most important factors in subjective self-
assessment of patient satisfaction and perception of the 
surgical treatment received (2).
Despite efforts to prevent postoperative discomfort, im-
mediate side effects of surgical extraction of impacted 
lower third molars include bleeding at the site of ex-
traction, inflammation, pain, dysphagia and trismus (1). 
Other complications may arise, such as alveolar osteitis 
(0.3%-26%) (3), damage to the adjacent tooth (0.3%-
0.4%) (4), hematoma (0.2%-5.8%) (3) and/or transient 
paresthesia, which can lead to permanent paresthesia 
(inferior alveolar nerve 0.35%; lingual nerve 0.69%) (3). 
Rarer complications include mandible fracture, the pa-
tient inhaling the tooth, and oro-antral communication 
(2).
Cicatrization is a physiological process through which 
the loss of integrity of oral mucosa is recovered and 
damaged tissues are repaired (5). The process begins 
with hemostasis and leads to three dynamic, interrelated 
phases: the inflammatory, proliferative and remodeling 
phases (5,6). These involve cell migration and transmi-
gration, vasoconstriction, vasodilatation, angiogenesis, 
granulation tissue formation and extracellular matrix 
deposition. 
Clearly, bacteria play a primary role in the processes 
of fibrinolysis, inflammation and poor healing, which 
appear as a result of infection at the extraction site (7). 
The most effective method of reducing risk of infection 
involves the use of topical or systemic agents that help 
eliminate oral bacteria (8).
Bexident Post is a topical gel commercialized by ISDIN 
labs (ISDIN, Spain) that contains chitosan, 0.2% chlo-
rhexidine, allantoin and dexpanthenol. While evidence 
of clinical benefits exists for each of its components, 
there are no published clinical trials demonstrating its 
therapeutic benefits as a whole. 
The present study seeks to clinically evaluate the effica-
cy of a gel containing chitosan, 0.2% chlorhexidine, al-
lantoin and dexpanthenol in postoperative improvement 
after extraction of an impacted mandibular third molar. 
Observations were made of wound healing and reduc-
tion of postoperative side effects and/or complications 
(pain, inflammation, infectious complications, trismus, 
amount of analgesics required and patients’ overall per-
ception of the procedure).
Material and Methods
This prospective clinical split-mouth design study eval-
uated 25 patients from the dental school at the Univer-
sity of Seville in Spain. This study was approved by the 
Ethical Committee of Virgen del Rocío Hospital (Se-
ville, Spain). The patients were treated between January 
2012 and March 2013, requiring bilateral extraction of 
impacted lower third molars.
The selected patients were both male and female, aged 
18 to 45, with symmetrically impacted lower third mo-
lars. They had a score between 5 and 7 on the Koerner 
Difficulty Index, exhibited no symptoms 15 days before 
surgery, had not taken any antibiotics or antiseptics 15 
days before the surgery, and were highly eligible can-
didates for preventive extraction. Ineligible patients 
included those who did not understand the clinical pro-
cedures of the study, individuals allergic or intolerant to 
substances used in the study, patients receiving treat-
ment affecting blood coagulation, patients under psy-
chiatric treatment, pregnant or lactating women, women 
taking oral contraceptives, diabetic patients, individuals 
with periodontal disease or active infection, smokers of 
more than 10 cigarettes per day, patients with poor oral 
hygiene, and uncooperative patients, in addition to any 
patients whose surgical procedure lasted longer than 30 
minutes. 
A total of 50 extractions (25 patients) were randomly as-
signed to one of two groups: Experimental Group (EG) 
or Control Group (CG). The only difference between 
the two groups in terms of surgery protocol was that the 
EG applied 10 ml of topical gel composed of chitosan, 
0.2% chlorhexidine, allantoin and dexpanthenol on the 
surgical wound three times a day for 10 days; patients in 
the CG did not apply any gel.
All patients were aware of the purpose of the present 
study and provided written consent of their participa-
tion. Patients’ complete medical history was reviewed, 
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identifying their age, sex, hygiene practices, diet and 
toxic habits. The split-mouth study design guarantees 
a homogeneous distribution of confounding variables. 
Mouth opening and location of facial reference points 
were measured and identified prior to operation.
The same protocol was followed for all patients. The 
left impacted lower third molar was surgically removed 
with a follow-up period of 14 days, and after a washout 
period of 15 days the right impacted lower third molar 
was removed. The website www.random.org was used 
to assign every third molar to one of the two groups. 
They were assigned to a group after the first surgery, 
with the second (right) third molars automatically as-
signed to the other group. While the surgeon who car-
ried out the surgeries and the patients were aware of 
which group they had been assigned, the practitioner 
who provided the follow-up evaluation was not. 
The same surgeon performed all surgical procedures 
using the standard surgical technique described below. 
Additionally, patients received a follow-up evaluation 
from the same clinician (different from the surgeon). 
The anesthetic used was 4% articaine with 1:100,000 
adrenaline. In all patients, an envelope incision was made 
with a vertical extension mesial to the lower second mo-
lar, a mucoperiosteal flap was raised, ostectomy was per-
formed using a No. 8 tungsten carbide bur on a surgical 
handpiece, and finally, a straight elevator was used to fin-
ish the extraction. If necessary, the molar was sectioned 
using a dental high-speed handpiece and fissure bur. The 
wound was irrigated with plenty of saline solution and 
wound edges were carefully sutured with simple inter-
rupted stitches using 4.0 silk braided non-absorbable su-
tures (Laboratorio Aragó S. A.; Barcelona, Spain).
Patients were prescribed amoxicillin/clavulanate (875 
mg/125 mg) and Ibuprofen (600 mg), to be taken every 
8 hours for 7 days. They were also prescribed 500 mg 
of paracetamol (acetaminophen) for use as a rescue an-
algesic as need. The only difference between the two 
groups in terms of surgery protocol was that the EG ap-
plied 10 ml of topical gel composed of chitosan, 0.2% 
chlorhexidine, allantoin and dexpanthenol on the sur-
gical wound three times a day for 10 days; patients in 
the CG did not apply any gel. Treatment compliance is 
certified with the collection of the excess gel.
The following variables were measured: wound consist-
ency and appearance were categorized as good, accept-
able or bad (Table 1, Fig. 1). Preoperative and postop-
erative pain levels were recorded for 14 days following 
the surgery (beginning 6 hours after surgery) using a 
visual analog scale from 0 to 10 (with 0 being no pain 
at all and 10 the worst possible pain). Level of inflam-
mation was recorded both 3 and 8 days post-surgery by 
measuring in millimeters the following facial points, 
which represented the overall size of the patient’s face 
GOOD ACEPTABLE BAD
Wound edges
Aesthetic, clean, good 
opposing edges Slightly irregular, light bleeding or erythema
Irregular, moderate or heavy bleeding, 
exudate, pus, foul odor. Signs of infec-
tion.
Color of the 
oral mucosa
Identical to the sur-
rounding area
Similar to the surrounding 
area Erythematous
Wound closure Complete / no dehis-cence 1 - 2 mm dehiscence
Dehiscence > 2 mm, open wound. Keloid 
formation or unaesthetic closure
Table 1. Criteria used to assess the wound’s healing process.
Fig. 1. Acceptable wound healing. Note the dehiscence in the horizontal incision (A) and the vertical incision discharge (B). Good wound heal-
ing. Note the lack of dehiscence, among other aspects (C). 
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at any given time: mandibular angle, tragus, lateral 
canthus of the eye, the base of the nasal ala, oral com-
missures and pogonion. These values were then used to 
make the following calculation: Postoperative measure-
ment (mm) - preoperative measurement (mm) = amount 
of inflammation (mm). Level of trismus was determined 
by measuring the interincisal distance 3 and 8 days 
post-surgery using a scaled ruler. Patients’ overall treat-
ment tolerance was recorded on a visual analog scale 
from 1 to 5, with 1 being a good level of tolerance to a 
compound and 5 a very bad one. Total surgery time was 
also recorded, with any surgery procedures that lasted 
longer than 30 minutes being excluded.
Statistical analysis was carried out using the IBM SPSS 
Statistics v.23 software (IBM, United States). Descrip-
tive parameters (frequency, mean and standard devia-
tion) of the recorded variables were calculated. The dif-
ference between both groups was assessed using the 
independent-samples t-test (p<0.05) and the Chi-square 
test.
Results
The mean age of patients was 26.47 years ± 6.74 in both 
groups. Both groups had an equal gender distribution 
(15 men, 60% and 10 women, 40%), neither group had 
any prior medical history or allergies, and there were 
no differences found in hygiene practices, diet or toxic 
habits. 
The average time of extraction was 14.34 minutes ± 3.45 
in the EG and 13.76 ± 4.32 minutes in the CG. The diffi-
culty index was 6.05 ± 0.65 in the EG and 6.01 ± 0.54 in 
the CG. Initial limitation of mouth opening was similar 
in both groups (EG=52.56 mm ± 6.9; CG=52.1 mm ± 
6.94). No significant differences were found. Initial fa-
cial measurements were 19.86 mm ± 1.27 in the EG and 
19.61 mm ± 1.10 in the CG (Table 2, p>0.05). 
Throughout the postoperative period, no significant dif-
ference in swelling and pain was observed between the 
two groups. There was a slight improvement in swelling 
of the EG during the first days after the surgery, but not 
enough to be deemed significant (Fig. 2). No significant 
differences were found in limitation of mouth opening 
or facial swelling (level of inflammation) during the 
study’s follow-up evaluations (Table 2). The statistical 
power to identify a change in the mouth opening of 5 
mm (50 to 55 mm for example), with a standard devia-
tion of 7 mm and 25 patients per group was 81.1%. The 
statistical power to identify a change of 1.5 cm in facial 
swelling (for example, from 20 cm to 21.5 cm), with a 
standard deviation of 1.5 and 25 patients per group was 
97.1%.
Wound appearance and consistency were better in the 
EG, both on day 7 (good healing, 20/25 (80%) vs. 7/25 
(28%), p=0.001) and day 14 (good healing, 21/25 (84%) 
vs. 12/25 (48%), p=0.01) of follow-up. Neither of the 
groups displayed poor healing or infectious complica-
tions of the wound throughout the postoperative period 
(Table 2, Fig. 3). Overall treatment tolerance was satis-
factory and similar in both groups (4.32 ± 0.54 p>0.5). 
Discussion
A total of 50 impacted lower third molar extractions 
were evaluated. They were divided into two groups: 25 
in the Control Group and 25 in the Experimental Group. 
Both groups displayed similar characteristics, an ad-
vantage of the split-mouth study design. No significant 
differences were seen in the surgical difficulty index or 
the time it took to complete the surgery. The same sur-
geon performed all surgeries included in this study, and 
the same clinician (different from the surgeon) carried 
out the follow-up evaluation of all patients. No allergic 
reactions or infectious complications were observed af-
ter the surgery. Wound healing was deemed either good 
or acceptable in all cases; no wound was categorized 
              VARIABLE EXPERIMENTAL GROUP       CONTRL GROUP    P
Mouth opening
 Day 1 52.56 ± 6.90 52.1 ± 6.94 0.82
Day 7 48.52 ± 8.96 46.25 ± 9.56 0.42
Day 14 50.39 ± 7.15 50.75 ± 7.43 0. 87
Facial swelling
Day 1 19.86 ± 1.27 19.61 ± 1.10 0.49
Day 7 20.10 ± 1.14 19.87 ± 1.22 0.52
Day 14 19.93 ±0.20 19.87 ± 1.01 0.86
Wound healing
Day 7 Good Acceptable Bad Good Acceptable Bad 0.001
20 5 0 7 18 0
Day 14
Good Acceptable Bad Good Acceptable Bad
0.01
21 4 0 12 13 0
Table 2. Comparative table of mouth opening, facial measurements and wound healing in the experimental and control groups.
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negatively. However, some significant differences were 
seen in improved appearance and wound closure in the 
group treated with the topical gel under study (EG).
The clinical indications of the topical gel containing 
chitosan, 0.2% chlorhexidine, allantoin and dexpan-
thenol, (Bexident Post, ISDIN, Spain) are well known; 
however, there are no published clinical trials demon-
strating its therapeutic effectiveness as a whole. Never-
theless, there are various different publications on the 
therapeutic uses of each component.
Allantoin (5-ureidohydantoin) has numerous widely cit-
ed pharmacological uses, including wound healing (9), 
anti-irritation, hydration and regeneration of tissue (9) 
and cell proliferation (10), as well as having analgesic 
(11), keratolytic (12) and epithelially stimulating effects 
(11). Although allantoin has been used for over 70 years, 
especially as a wound healer, not enough clinical trials 
exist and so its mechanism of action remains unknown 
(13).
Chlorhexidine (CHX) is a bis-guanide antiseptic that 
displays a wide range of antimicrobial activity, in ad-
dition to its safety, effectiveness, substantivity and low 
toxicity (5). CHX now comes in many different forms, 
including mouthwashes, bioadhesive gels, dental var-
nishes, and chips (1,7).
Chitosan is a naturally non-toxic, bioactive polysaccha-
ride that lends itself to a wide range of biomedical ap-
plications due to its high compatibility, biodegradation 
and cationic nature, as opposed to other polysaccha-
rides with a neutral or negative charge (14). The proper-
ties and many uses of chitosan and its derivatives have 
been noted in various different studies (14-17). Chitosan 
is known for its antibacterial, antifungal, antioxidant, 
anti-diabetic and anti-inflammatory uses, in addition to 
its cholesterol-lowering properties.
Within the skin, dexpanthenol (provitamin B5) is me-
tabolized into pantothenic acid (vitamin B5), which is 
essential for the normal functioning of epithelial cells, 
Fig. 2. Comparative chart of pain (A) and swelling (B) levels of both groups during the postoperative period. 
Fig. 3. Wound healing of both groups on day 7 (A) and day 14 (B) of the study.
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especially during the first phase of epithelial regenera-
tion (within the first four days) (18,19). Dexpanthenol 
has been used in dermatological applications to treat 
wound healing disorders, dermatosis, scratches, ex-
tensive burns or skin transplants (18-20). For decades, 
dermatologists have routinely used dexpanthenol for its 
anti-inflammatory effects and its role in epithelial pro-
tection (18). 
All the information collected shows that this is the first 
published clinical trial to evaluate a combination of 
0.2% chlorhexidine, allantoin, chitosan and dexpanthe-
nol as used to aid in postoperative healing (Bexident 
Post, ISDIN, Spain). The most satisfactory results were 
observed in wound healing after extraction of an im-
pacted lower third molar. Although there are no similar 
studies with which to compare the present study, its re-
sults can still be compared with those of clinical trials 
evaluating the different compounds mentioned, as well 
as with other studies that also seek to improve postop-
erative healing after oral surgery. This information is 
further supported by already published proof of each 
compound’s efficacy.
Use of 0.2% chlorhexidine mouthwash and bioadhesive 
gel before and after surgery appears to play an impor-
tant role in the improvement of preoperative oral hygiene 
conditions, which improves the wound healing process. 
However, these results are controversial (21,22). Similar-
ly, topical application of minocycline or lincomicin dur-
ing and after surgery yields positive results and improves 
the patient’s quality of life after surgery (22).
A recent study compared the effects of a gel composed of 
onion extract, sodium heparin and allantoin on the wound 
healing process. Results found significant improvement 
in the quality of cicatrization, as well as reduced forma-
tion of keloids and/or hypertrophic scars (23). 
Another clinical trial was found in which a 3 mm inci-
sion was made on the palate of 125 rats. There were 4 
experimental groups and 1 control group; each of the 
five groups received 0.2% chlorhexidine gel, hyaluron-
ic acid gel, 0.5% allantoin gel, placebo gel or nothing, 
respectively. None of the tested agents were shown to 
adversely affect wound healing. The best results were 
obtained in the groups in which 0.2% chlorhexidine and 
hyaluronic acid were applied (24).
Chitosan’s effects on wound healing after oral surgery 
are best seen in a study conducted on the effects of lo-
cal application of glutathione (GHS) and chitosan on 
oxidative processes and the histological changes that 
occur in the oral mucosa of rats during the wound heal-
ing process. According to the histological findings, the 
group treated with chitosan showed better results than 
the other groups. The study demonstrated that local ap-
plication of chitosan on intraoral wounds, whether by 
itself or mixed with glutathione, can aid in the wound 
healing processes of soft tissues (25).
Finally, one study examined dexpanthenol’s effective-
ness in pediatric pain management after frenectomy and 
throughout the wound healing process. The group that 
took dexpanthenol suffered less pain than the placebo 
group, and wound healing was accelerated (26).
Other research includes the postoperative use of hy-
aluronic acid gel, which has anti-inflammatory effects, 
although oxidative stress and clinical results are simi-
lar by one week after surgery (27); platelet-rich plasma 
(PRP) and platelet-rich fibrin (PRF), which proved very 
beneficial in the cicatrization of soft tissue and helped 
speed up the wound’s healing process (28); and photo-
dynamic and ozone therapy, which reduce bleeding and 
exudate, decrease the wound’s temperature and improve 
the patient’s quality of life during the postoperative pe-
riod (29).
The relationship between psychological and physiologi-
cal variables in predicting the likelihood of good post-
operative recovery has also been studied. Results show 
that psychological factors such as stress, high need for 
a sense of control or overly vigilant attitude may influ-
ence the postoperative process, regardless of the effects 
of any physical trauma resulting from the surgery (30).
Apart from its limited sample size, the main limitation 
of the present study is that it is not a double-blind trial. 
Results showed a significant improvement in healing of 
the surgical wound when a gel comprised of chitosan, 
0.2% chlorhexidine, allantoin and dexpanthenol (Bexi-
dent Post, ISDIN, Spain) was applied after extraction 
of impacted third molars. Patients can benefit from an 
effective, simple and accessible measure that increases 
the likelihood of a favorable outcome in the closure and 
healing of wounds after extraction of an impacted low-
er third molar. However, the gel does not help prevent 
swelling or pain, both of which can be alleviated with 
other medication. 
In conclusion, the collected data highlight a need for 
further research to evaluate the gel’s effect on a larger 
patient sample size, comparing it with a placebo group 
and/or current methods of postoperative treatment. 
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